Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11
Patients with cerebrovascular disease (CeVD) have been shown to benefit from lipid-lowering therapies, but guideline-recommended levels of low-density lipoprotein cholesterol (LDL-C) are often not attained with statin treatment alone. The ORION-9, ORION-10, and ORION-11 trials evaluated the efficacy...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2023-06-01
|
| Serier: | American Journal of Preventive Cardiology |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2666667723000442 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
